LABORATORIOS DEL DR. ESTEVE, S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 65190
 
  
 
C07D HETEROCYCLIC COMPOUNDS 47115
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9158
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 6132
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 6200
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 590
 
  
 
C07K PEPTIDES 5131
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
B32B LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM1156

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0021,309 SIGMA LIGANDS FOR POTENTIATING THE ANALGESIC EFFECT OF OPIOIDS AND OPIATES IN POST-OPERATIVE PAIN AND ATTENUATING THE DEPENDENCY THEREOFAug 03, 17Jan 25, 18[A61K]
2017/0354,648 1,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAINNov 20, 15Dec 14, 17[A61K, C07D]
2017/0273,948 USE OF SIGMA RECEPTOR LIGANDS IN OSTEOARTHRITISDec 15, 15Sep 28, 17[A61K]
2017/0202,950 HIGHLY IMMUNOGENIC HIV P24 SEQUENCESMar 20, 17Jul 20, 17[A61K, C12N, C07K]
2017/0112,829 USE OF COMPOUNDS BINDING TO THE SIGMA RECEPTOR LIGANDS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPYJan 10, 17Apr 27, 17[A61K]
2017/0101,420 ALKYL AND ARYL DERIVATIVES OF 1-OXA-4,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAINJun 02, 15Apr 13, 17[C07D]
2016/0310,501 GABAPENTINOIDS AND SIGMA RECEPTOR LIGANDS COMBINATIONSDec 16, 14Oct 27, 16[A61K]
2016/0220,574 NSAID AND SIGMA RECEPTOR LIGAND COMBINATIONSSep 11, 14Aug 04, 16[A61K]
2016/0220,575 Sigma Ligands For the Prevention or Treatment of Pain Induced by ChemotherapyApr 07, 16Aug 04, 16[A61K]
2016/0199,380 Sigma Ligands For the Prevention or Treatment of Pain Induced by ChemotherapyMar 17, 16Jul 14, 16[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914705 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereofSep 30, 14Mar 13, 18[A61K, C07D]
9902711 Piperidine compounds having multimodal activity against painDec 19, 14Feb 27, 18[C07D]
9879015 Pyrazino[1,2-a]indole compounds, their preparation and use in medicamentsApr 22, 14Jan 30, 18[A61K, C07D]
9844516 Sigma ligands for use in the prevention and/or treatment of post-operative painFeb 04, 11Dec 19, 17[A61K]
9789115 Use of sigma ligands in opioid-induced hyperalgesiaAug 02, 11Oct 17, 17[A61K]
9789117 Use of sigma ligands in diabetes type-2 associated painMay 18, 12Oct 17, 17[A61K, C07D]
9789130 Method for blocking HIV entry into dendritic cells by inhibiting sialoadhesin-sialyllactose binding interactions with gangliosidesDec 17, 12Oct 17, 17[A61K, G01N, C07K]
9782483 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapyMay 20, 11Oct 10, 17[A61K, C07D]
9757358 Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereofFeb 04, 11Sep 12, 17[A61K]
9709577 Method for monitoring HIV specific T cell responsesMar 22, 13Jul 18, 17[G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0000,799 ORAL PHARMACEUTICAL COMPOSITIONAbandonedDec 19, 14Jan 05, 17[A61K]
2015/0211,012 MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINEAbandonedJul 02, 13Jul 30, 15[A61K, C12N]
2015/0196,503 CO-CRYSTALS OF TRAMADOL AND COXIBSAbandonedMar 23, 15Jul 16, 15[A61K]
2015/0196,504 CO-CRYSTALS OF TRAMADOL AND COXIBSAbandonedMar 23, 15Jul 16, 15[A61K]
2015/0164,920 CONTROLLED RELEASE FORMULATION COMPRISING MESALAMINEAbandonedMar 27, 13Jun 18, 15[A61K]
2015/0150,889 COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE TREATMENT OF PAINAbandonedFeb 04, 15Jun 04, 15[A61K]
2015/0125,489 METHOD FOR THE PREPARATION OF DENDRITIC CELL VACCINESAbandonedMar 01, 13May 07, 15[A61K, C12N]
2014/0255,503 PHARMACEUTICAL COMPOSITION OF OMEPRAZOLEAbandonedOct 31, 12Sep 11, 14[A61K]
2014/0148,499 METHODS AND REAGENTS FOR EFFICIENT CONTROL OF HIV PROGRESSIONAbandonedJul 12, 12May 29, 14[A61K, C12Q, C12N]
2014/0024,622 COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE TREATMENT OF PAINAbandonedSep 25, 13Jan 23, 14[A61K]
2013/0302,364 HIGHLY IMMUNOGENIC HIV P24 SEQUENCESAbandonedNov 10, 11Nov 14, 13[A61K]
2013/0280,325 COMPRESSED SOLID DOSAGE FORMSAbandonedDec 22, 11Oct 24, 13[A61K]
8492425 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitorsExpiredApr 27, 09Jul 23, 13[A61K, C07D]
2013/0143,884 4-[2-[ [5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL] MORPHOLINE SALTSAbandonedNov 25, 10Jun 06, 13[C07D]
8410159 Imidazole compounds having pharmaceutical activity towards the sigma receptorExpiredJul 29, 11Apr 02, 13[A61K, C07D]
2013/0072,534 COMPOSITIONS COMPRISING VENLAFAXINE AND CELECOXIB IN THE TREATMENT OF PAINAbandonedDec 23, 10Mar 21, 13[A61K]
2013/0028,937 CO-CRYSTALS OF VENLAFAXINE AND CELECOXIBAbandonedDec 23, 10Jan 31, 13[A61K, A61P]
2012/0321,702 PHARMACEUTICAL COMPOSITION OF LANSOPRAZOLEAbandonedJun 27, 11Dec 20, 12[A61K, A61P]
2012/0322,842 HETEROCYCYL-SUBSTITUTED-ALKYLAMINOPHENYL DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTSAbandonedSep 22, 10Dec 20, 12[A61K, C07D, A61P]
2012/0264,799 INDANE-AMINE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTSAbandonedSep 29, 10Oct 18, 12[A61K, C07D, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.